Archean Chemical Industries share price today

Archean Chemical Industries Ltd's share price was ₹428.90 at the close on 4 November 2026. It has been falling for 22 weeks. That is 19.1% below its average price over the last 200 trading days. In the last 52 weeks it traded between ₹429 and ₹635, and at that close it was at the low of that range.

A share price tends to move through four phases: moving sideways (stage 1), rising (stage 2), stalling near a high (stage 3) and falling (stage 4). Today Archean Chemical Industries Ltd is in stage 4. The phase helps read everything below.

Over the past 13 weeks it has done worse than the NIFTY 500, and it has been behind for 15 weeks running.

Over the last 3.9 years the share price moved −20% while the NIFTY 500 moved +37%, so it is behind the index over that whole period. It was last ahead over 13 weeks in the week of 24 July 2026. The chart above shows the 13-week comparison for every week.

This page treats a rise as over when the price closes below its 200-day average on two Fridays in a row.

Two changes stood out: profit grew again in the September 2026 quarter and operating margin down 3 points on a year earlier.

1. Profit grew again in the September 2026 quarter

   Profit was ₹31 crore, +6.9% on a year earlier (₹29 crore), after 3 quarters of decline.

2. Operating margin down 3 points on a year earlier

   24% in the September 2026 quarter, from 27%.

For July to September 2026 (the quarter ended 30 September 2026), Archean Chemical Industries reported revenue of ₹297 crore, up 27.5% from ₹233 crore a year earlier, and a profit of ₹31.0 crore, up 6.9% from ₹29.0 crore.

Archean Chemical Industries results: July to September 2026 against a year earlier

The next results, for October to December 2026, are due by 14 February 2027: listed companies must publish quarterly results within 45 days of the quarter's end (60 days for the January to March quarter).

The newest call in our records is from 3 August 2026, about April to June 2026; a call about these results is not in our records yet.

From the company's reported quarterly results (quarter ended 30 September 2026). Revenue and profit in ₹ crore.

Archean Chemical Industries closed at ₹428.90 on 4 November 2026, down 32.4% from ₹634.60 a year earlier (7 November 2025) and down 17.1% over three years. Its highest weekly close since November 2022 was ₹801.20 on 23 August 2024.

Archean Chemical Industries share price: then and now

Weekly closing prices. Each change is the move from that price to the 4 Nov 2026 close. A day's intraday high or low can go beyond these weekly closes.

212 weekly closes from 25 November 2022 to 4 November 2026.

4 Nov 2026: Archean Chemical Industries closed at ₹428.90, down 3.0% on the week and down 9.7% on the month. Results for July to September 2026: Revenue up 27.5% and profit up 6.9% on a year earlier.

Earlier

• 3 Aug 2026: Archean Chemical Industries held its results call for April to June 2026. Management guided: Bromine exit FY27 run rate of 20,000-25,000 tons, with FY28 full-year output planned around the same level.
• 5 Jun 2026: ex-date for a dividend of ₹2.50 a share.

Archean Chemical Industries paid ₹2.50 a share in regular dividends in the 12 months to 5 November 2026 (1 payment), a yield of 0.58% at the ₹428.90 close on 4 November 2026. The last was a dividend of ₹2.50 a share, ex-date 5 June 2026.

Archean Chemical Industries dividends since 1 April 2021

Amounts as the company declared them on the NSE. A dividend goes to whoever owns the shares before the ex-date. The record date is the same day as the ex-date for every payment here.

Yes. Archean Chemical Industries Ltd paid out 29% of its profit as dividends in FY26, and it paid a dividend in 4 of its last 6 reported years.

From the NSE corporate-actions record, read 5 November 2026.

On the call for April to June 2026, held on 3 August 2026, Archean Chemical Industries' management guided: Bromine exit FY27 run rate of 20,000-25,000 tons, with FY28 full-year output planned around the same level.

“At a headline level, a large part of this cost increase will be mitigated as the reset happens. As fuel prices come down and routes are reset, this is not a structural cost increase.”Ranjit, on the call for April to June 2026

What management guided

• Bromine realization near ₹300 per kg and most implemented price increases retained through FY27.
• Highway work to finish by end September; salt volumes normalize from Q3 and deliver double-digit growth thereafter.
• SOP phase-two trials by December and scale-up complete by year-end; full-year throughput of 9,000-10,000 tons.
• ACUM derivatives to scale beyond break-even as utilization and organic mix build; oilfield chemicals to produce meaningful PAC and starch volumes in H2 and bentonite by year-end.

Management’s own plans and goals, from our notes of the call. A plan is not a result.

Source: the call transcript.

From the call for April to June 2026, 3 August 2026. The July to September 2026 results are out since, so this part may be out of date until we update it.

When Archean Chemical Industries reports October to December 2026, these are the 4 checks that show whether the story is still on course. First: Salt dispatches and freight costs to normalize after highway completion; check whether recovery starts as management expects.

Archean Chemical Industries is on one of our India lists: 52 week high & low.

Archean Chemical Industries Ltd earned ₹31.0 Cr of net profit in the Sep 2026 quarter, +6.9% on the same quarter a year earlier. Full-year FY26 profit was ₹105 Cr. That is 10.4% of the quarter's revenue. The same quarter a year earlier earned ₹29.0 Cr.

Net profit is what is left after every cost, interest and tax. Earnings per share, dividends and book value all grow from it.

For the full year, FY26 profit was ₹105 Cr (−35.2% on the year before).

Why profit moved: revenue changed +27.5% on a year earlier and the margin moved −3.0 percentage points. Sales did the work while the margin got thinner.

On average over the last four quarters, profit changed −36.5% and revenue +8.0%. Profit is growing slower than sales: rising costs are taking part of the growth.

Archean Chemical Industries Ltd reported ₹297 Cr of revenue in the Sep 2026 quarter, +27.5% on the same quarter a year earlier. That is the 2nd quarter in a row with growth on the year before. Over 6 years it has grown 10.1% a year on average. The last full year, FY26, came in at ₹1,081 Cr.

Revenue is everything the company billed its customers in the period.

The last four reported quarters add to ₹1,180 Cr.

FY26 revenue was ₹1,081 Cr, +3.8% on the year before.

Recent pace: the last four quarters grew +8.0% on average, against 10.1% a year over the longer run, so this year is growing slower than its own long-run rate.

Is growth speeding up? Revenue over the last 12 months grew +6.0%, against +1.3% a year over the last 8 quarters (accelerating); profit over the last 12 months grew −43.3%, against −33.7% a year (rolling over).

Archean Chemical Industries Ltd's operating margin was 24.0% in the Sep 2026 quarter, 3.0 percentage points lower than the same quarter a year ago. Across 6 years it has been between 22.0% and 44.0%. The latest quarter is within that range.

Operating margin is what is left from every ₹100 of sales after the costs of running the business, before interest and tax. It shows pricing power and cost control.

Why the margin moved: operating margin changed −3.2 percentage points on the year while gross margin changed −7.5 points. So the drop came mostly from the gross margin, which means input costs and prices charged.

Over the last 3 years, 119% of Archean Chemical Industries Ltd's reported profit came in as cash from its operations, so the profit is backed by cash. In FY26 it brought in ₹140 Cr of operating cash against ₹105 Cr of profit.

The profit and loss account shows what was earned. The cash-flow statement shows the cash that actually came in. Comparing operating cash flow with profit is one of the best checks that a profit is real.

After ₹211 Cr of spending on assets, free cash was −₹71.0 Cr: it spent more than its operations brought in.

Cash-flow figures here are yearly, because quarterly cash statements are not published, so this section changes once a year.

Why: the cash figure is clear, but the day counts behind it are not in our data, so we show it without guessing the reason.

What to look at next: the main use of cash is spending on assets. The next section checks what that spending is building.

Archean Chemical Industries Ltd's customer, stock and supplier day counts come out in the thousands of days on sales this small (₹1,081 Cr in FY26), so no cash-cycle chart is drawn and this section looks at its spending on assets instead. It spent ₹661 Cr on assets over the last 3 years.

Working capital is the cash tied up between paying suppliers and getting paid. Debtor days: how long customers take to pay. Inventory days: how long stock sits. The cash cycle: the whole loop, in days of sales.

Averaged over those years that is 20.4% of FY26 revenue a year.

Spending on assets: ₹661 Cr over the last 3 years, against ₹242 Cr of depreciation (the yearly wear and tear on existing assets). So it is building well beyond replacing what wears out. Work still in progress is ₹182 Cr (FY26): assets paid for that are not earning yet.

In short: the cash is going into new capacity, not getting stuck in the daily cycle. The question is whether the new capacity earns.

Archean Chemical Industries Ltd's P/E is 53.1×, near the high end of its own history: higher than 86% of past readings. Its usual P/E (the middle reading) is 36.1×, over 3.9 years of weekly prices. This compares the share price with the company’s own past. It does not say what the business is worth.

P/E is the share price divided by a year's profit per share: how many rupees the market pays for each rupee of yearly profit.

Why the multiple is where it is: over the past year earnings per share moved −34.1% while the price moved −32.4%. The price did better than earnings, which pushed the multiple up within its own range.

Where the price move came from: over 3 years the price moved −6.1% a year; about −36.6% a year came from earnings growth and about +30.5 percentage points from the multiple (the market paying more). The split is approximate (price return minus earnings growth). It shows how much of the move came from the market paying a different multiple.

In short: the multiple is high against its own past, so the earnings trend underneath matters more than the multiple.

Archean Chemical Industries Ltd's business is getting worse. Profit and EPS growth are shrinking: profit growth is −43.3% in the latest quarter, against +21.6% at its best in 12 quarters, with ROCE falling at 7.1%. This is based on 12 quarters of 4 measures.

Every business is somewhere on a path of getting better or worse, and this section names where. The last 12 quarters of growth in revenue, profit and earnings per share, plus the return the business earns on its capital, are read as lines. Getting worse: the lines are falling. Turning around: a low point has just formed and the last few quarters are rising from it. Getting better: the rise from the low has lasted. Growing steadily: steady growth with healthy returns. Slowing from a peak: still high, but slowing. When the lines disagree the result is mixed; too little history means no reading. CAGR (compound annual growth rate) is the steady yearly rate that would turn the starting value into the latest one. It is the fairest way to compare growth over different periods. If the 1-year figure is much bigger than the 10-year one, recent growth is running faster than the long-run trend. A dash means there is no figure for that period, or the starting year was a loss, where a growth rate means nothing.

Why it matters: falling lines mean any ratio below that looks low should be read with that direction in mind.

Compound annual growth rate (%)

Compound annual growth rate over each period, %. Revenue, profit and EPS come from yearly figures; the share price row is price growth over the same periods. A dash means no figure for that period, or the starting year was a loss.

Archean Chemical Industries Ltd earned a ROCE of 7% in FY26. Its return on capital used (ROIC) is 7.8 percentage points below its cost of capital, so growth here does not yet pay for the capital it uses. It comes from a 9.7% net margin and 0.41× asset turnover (sales divided by assets).

Return on capital employed (ROCE) is the profit the whole business earns on all the money in it, from shareholders and lenders together. It is the best single test of whether growth adds value or just size.

Why the return is what it is (FY26): a 9.7% net margin × 0.41× asset turnover × 1.38× leverage (assets divided by equity) ≈ 5.5% on equity. The margin does its share; borrowing plays a small part, so this return is earned, not borrowed.

The key test, return on capital used minus the cost of capital: 4.2% − 12.0% = −7.8 percentage points. The 12.0% is a standard assumption for the cost of capital in India, not an estimate for this company. Read the sign and size of the gap, not the decimals. Negative: growth at these returns loses value until returns improve.

Archean Chemical Industries Ltd has total debt of ₹551 Cr against shareholder equity of ₹1,961 Cr as of Sep 2026, so its debt is 0.28× its equity, which is very little. Year by year, that ratio went from 12.58 in FY21 to 0.24 in FY26. So the returns on this page come from the business, not from borrowed money.

Debt-to-equity shows how much of the business is paid for with borrowed money. Lower is safer, and the direction matters as much as the level.

No group of Archean Chemical Industries Ltd's owners changed its stake by a full percentage point over the last two years. Foreign institutions moved +0.2 points over the same period, to 10.4%. This uses the four owner groups that companies report every quarter; nothing is guessed between filings.

Who owns the company each quarter: promoters (the founders or controlling owners), foreign institutions, domestic institutions such as mutual funds, and the public. When people close to the business steadily raise their stake, that is worth noticing; a quiet list is also an answer.

Over the last two years: Domestic institutions: −0.7 points over 8 quarters, to 21.3%; Foreign institutions: +0.2 points over 8 quarters, to 10.4%; Promoters: +0.0 points over 8 quarters, to 53.4%.

For Archean Chemical Industries Ltd, the Z-score is not available, so we say so rather than guess one. It estimates how far the balance sheet is from trouble; it is not a forecast of failure. The debt, cash-flow and return sections show the balance-sheet figures we do have, each with its own date.

The Z-score estimates how far a company is from balance-sheet trouble. Above about 3 is safe; below about 1.8 is the danger zone. It was built for manufacturers, so it is not used for banks and lenders.

30.3 out of 100, rank 8 of 9 in Chemicals - Inorganic, with 90% of the evidence available.

Archean Chemical Industries Ltd scores 30.3 out of 100 against the 9 companies it is compared with in Chemicals - Inorganic, ranking 8. The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer.

The four parts add up to the total exactly: 7.4 + 9.6 + 8.5 + 4.8 = 30.3. This is the same number shown on the industry page; it is worked out once for the whole group and read here.

What would change it: The score would fall if profit growth turns negative or margins stop improving while the share price lags its sector.

Archean Chemical Industries ranks 8 of 9 Chemicals - Inorganic companies on the 4-Factor Sector Score, with 30.3 out of 100.

Missing figures are not scored as bad. They lower the confidence and pull the final score toward the middle. Relative strength counts only when the company has a reading for this week; with no reading, that factor is left out and its 20 points are shared across the other three in proportion. PEG is not shown when the ratio cannot mean anything: the company must be making a profit, its price-to-earnings must be positive, and its three-year earnings growth must fall between 5% and 60%. Dividing a price multiple by a loss, or by growth measured off a tiny base, produces a number that looks precise and tells you nothing. Under relative strength, one mark per week shows the last 12 weeks: a mark is filled where the company led NIFTY 500 by 5% or more over the 13 weeks ending that week, which is the same test used everywhere on this site. Price stage places the company on the same six-step path the industry is placed on (basing, turning, breaking out, leader, fading, asleep), read from how many weeks running it has led NIFTY 500 and whether that lead is growing or shrinking. It describes where the share price stands, not the direction of earnings, and it is not a recommendation; it is left blank for a company whose weekly history is too short or too stale to read.

The figures in this ranking come from the industry comparison: results through the Sep 2026 quarter, and the P/E at that quarter's end. The sections above use the latest weekly price, so a P/E or return there can differ a little from the one here. The stage words in this ranking (such as losing its lead or breaking out) describe the lead over the index, not the price phase in the price section.

Related companies: Chemicals - Inorganic, all 9 compared on one page.

Archean Chemical Industries is the 3rd largest of 9 Chemicals - Inorganic companies on Sector Alpha by market value (scores of 30 October 2026). Just above it: Deepak Nitrite and Tanfac Industries. Just below it: J.G.Chemicals, Fischer Medical Ventures, Indo Borax & Chemicals and Sree Rayalaseema Hi-Strength Hypo.

Chemicals - Inorganic companies close in size

1. Deepak Nitrite Ltd ₹20,724 crore
2. Tanfac Industries Ltd ₹7,266 crore
3. Archean Chemical Industries Ltd ₹5,460 crore
4. J.G.Chemicals Ltd ₹2,258 crore
5. Fischer Medical Ventures Ltd ₹1,732 crore
6. Indo Borax & Chemicals Ltd ₹1,394 crore
7. Sree Rayalaseema Hi-Strength Hypo Ltd ₹833 crore

All 9 Chemicals - Inorganic companies, largest first

Companies close in size in other industries

805. KPI Green Energy Ltd ₹5,481 crore · Power - Generation/Distribution
806. GMM Pfaudler Ltd ₹5,464 crore · Glass - Others
807. Archean Chemical Industries Ltd ₹5,460 crore
808. Man Industries (India) Ltd ₹5,443 crore · Steel - Tubes/Pipes
809. Lohia Corp Ltd ₹5,419 crore · Textile machinery

Sector Alpha, written by code from the published numbers. Data as of 4 November 2026.

Every chart on this page is drawn by code from the published figures, with no forecasts and no price opinions.

See the plain-text version of this page.